Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 8, 2011, Pages 851-858

  Gadaleta, Raffaella M ^a,b   Oldenburg, Bas ^a   Willemsen, Ellen C L ^a   Spit, Maureen ^a   Murzilli, Stefania ^b,c   Salvatore, Lorena ^b   Klomp, Leo W J ^a   Siersema, Peter D ^a   van Erpecum, Karel J ^a   van Mil, Saskia W C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Santa Maria Imbaro   (Italy)

^c Sta Maria Imbaro (Ch)   (Italy)

Author keywords

Farnesoid X Receptor; Inflammatory bowel disease; Mutual inhibition; Nuclear factor B

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; DIMETHYL SULFOXIDE; FARNESOID X RECEPTOR; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; OBETICHOLIC ACID; PROTEIN P50; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; CARCINOMA CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FGF15/19 GENE; GENE; GENE TARGETING; HUMAN; HUMAN CELL; IBABP GENE; IN VITRO STUDY; INHIBITION KINETICS; INTERMETHOD COMPARISON; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BILE ACIDS AND SALTS; CELL LINE; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS;

EID: 79958278121     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.04.005     Document Type: Review

References (21)

1. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:390-407.
2. Abraham C., Cho J.H. Inflammatory bowel disease. N. Engl. J. Med. 2009, 361:2066-2078.
3. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P.A., Scholmerich J., Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998, 115:357-369.
4. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 1994, 10:405-455.
5. Siebenlist U., Brown K., Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 2005, 5:435-445.
6. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870.
7. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
8. Wang Y.D., Chen W.D., Moore D.D., Huang W. FXR: a metabolic regulator and cell protector. Cell Res. 2008, 18:1087-1095.
9. Gadaleta R.M., van Erpecum K.J., Oldenburg B., Willemsen E.C.L., Renooij W., Murzilli S., Klomp L.W.J., Siersema P.D., Schipper M.E.I., Danese S., Penna G., Laverny G., Adorini L., Moschetta A., van Mil S.W.C. Farnesoid X Receptor Activation Inhibits Inflammation and Preserves the Intestinal Barrier in Inflammatory Bowel Disease. Gut 2011, 60:463-472.
10. McKay L.I., Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 1999, 20:435-459.
11. Wang Y.D., Chen W.D., Wang M., Yu D., Forman B.M., Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 2008, 48:1632-1643.
12. Vavassori P., Mencarelli A., Renga B., Distrutti E., Fiorucci S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J. Immunol. 2009, 183:6251-6261.
13. Maloney P.R., Parks D.J., Haffner C.D., Fivush A.M., Chandra G., Plunket K.D., Creech K.L., Moore L.B., Wilson J.G., Lewis M.C., Jones S.A., Willson T.M. Identification of a chemical tool for the orphan nuclear receptor FXR. J. Med. Chem. 2000, 43:2971-2974.
14. van Mil S.W., Milona A., Dixon P.H., Mullenbach R., Geenes V.L., Chambers J., Shevchuk V., Moore G.E., Lammert F., Glantz A.G., Mattsson L.A., Whittaker J., Parker M.G., White R., Williamson C. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007, 133:507-516.
15. Milona A., Owen B.M., Cobbold J.F., Willemsen E.C., Cox I.J., Boudjelal M., Cairns W., Schoonjans K., Taylor-Robinson S.D., Klomp L.W., Parker M.G., White R., van Mil S.W., Williamson C. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 2010, 52:1341-1349.
16. Pellicciari R., Costantino G., Camaioni E., Sadeghpour B.M., Entrena A., Willson T.M., Fiorucci S., Clerici C., Gioiello A. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. J. Med. Chem. 2004, 47:4559-4569.
17. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702.
18. Inagaki T., Moschetta A., Lee Y.K., Peng L., Zhao G., Downes M., Yu R.T., Shelton J.M., Richardson J.A., Repa J.J., Mangelsdorf D.J., Kliewer S.A. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. U. S. A 2006, 103:3920-3925.
19. Mason A., Luketic V., Lindor K., Hirschfield G., Gordon S., Mayo M., Kowdley K., Parés A., Trauner M., Castelloe E., Sciacca C., Jones T.B., Böhm O., Shapiro D. Farnesoid-X receptor agonists: a new class of drugs for the treatment of PBC? An international study evaluating the addition of INT-747 to ursodeoxyxholic acid. J. Hepatol. 2011, Vol. 52(Supplement 1):S1-S2.
20. Fiorucci S., Clerici C., Antonelli E., Orlandi S., Goodwin B., Sadeghpour B.M., Sabatino G., Russo G., Castellani D., Willson T.M., Pruzanski M., Pellicciari R., Morelli A. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J. Pharmacol. Exp. Ther. 2005, 313:604-612.
21. Gu X., Ke S., Liu D., Sheng T., Thomas P.E., Rabson A.B., Gallo M.A., Xie W., Tian Y. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J. Biol. Chem. 2006, 281:17882-17889.